Chang Wei Lin, Akiyama Takuya, Wang Jia-Sheng, Yong Heng Yaw, Hassan Faezah, Abu Saad Hazizi, Jamaluddin Rosita, Sabran Mohd Redzwan
Department of Nutrition, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Yakult Central Institute, Yakult Honsha Co., Ltd., Tokyo, Japan.
J Nutr. 2025 Jul;155(7):2110-2121. doi: 10.1016/j.tjnut.2025.04.014. Epub 2025 Apr 16.
Limited evidence suggests that probiotic Lacticaseibacillus paracasei strain Shirota (LcS) may reduce aflatoxin exposure in Malaysians, though individual factors influencing aflatoxin exposure remain unclear.
This study evaluated the effect of LcS on aflatoxin biomarker concentrations over a 12-wk intervention among healthy Malaysian adults. A secondary objective was to explore the individual factors associated with aflatoxin exposure using baseline data.
A randomized, double-blind, placebo-controlled intervention involved healthy Malaysian adults (aged 20-60) of Chinese, Malay, or Indian ethnicities with elevated urinary aflatoxin M (AFM) and serum aflatoxin B (AFB)-albumin concentrations. Hundred and seventy-four (n = 174) subjects were randomly and equally assigned (n = 87/group) to consume either fermented milk with LcS (probiotic) (3 × 10 CFU/80 mL/bottle) or milk without LcS (placebo) twice/d for 12 wk, with a 4-wk follow-up. Baseline data included sociodemographic characteristics, knowledge, attitude, and practice related to aflatoxin contamination, dietary intake, body weight, and physical activity status. Urine and fasting blood samples were collected every 2 and 4 wk for AFM and AFB-lysine adduct analyses, respectively.
Eighty-five (n = 85) and 82 (n = 82) subjects in the probiotic and placebo groups completed the intervention, respectively. After adjusting for covariates, a significant effect was observed at postintervention in the probiotic group with a 23% reduction in urinary AFM concentrations compared with the placebo group (B = -0.26; Exp(B) = 0.77; P = 0.04). Serum AFB-lysine adduct concentrations remained lower in the probiotic group throughout the study. Both aflatoxin biomarkers significantly differed by ethnicity (AFM: P = 0.001; AFB: P = 0.01). Subjects with lower aflatoxin knowledge had significantly higher AFB-lysine concentrations (mean rank = 95.99) than those with higher knowledge (mean rank = 73.57) (P = 0.04). Urinary AFM concentrations were higher with cereal intake (ρ = 0.17, P = 0.03) but lower with protein intake (ρ = -0.18, P = 0.02).
Ethnicity, knowledge level, and dietary intake influenced aflatoxin exposure. The benefits of consuming LcS to reduce aflatoxin exposure deserve further attention.
This trial is registered in the National Medical Research Register (NMRR-16-2693-3230) and clinicaltrials.gov (NCT03882294).
有限的证据表明,益生菌副干酪乳杆菌Shirota株(LcS)可能会降低马来西亚人的黄曲霉毒素暴露量,不过影响黄曲霉毒素暴露的个体因素仍不明确。
本研究评估了LcS对健康马来西亚成年人进行12周干预后黄曲霉毒素生物标志物浓度的影响。第二个目的是利用基线数据探索与黄曲霉毒素暴露相关的个体因素。
一项随机、双盲、安慰剂对照干预研究纳入了20至60岁、尿黄曲霉毒素M(AFM)和血清黄曲霉毒素B(AFB)-白蛋白浓度升高的华裔、马来裔或印度裔健康马来西亚成年人。174名受试者被随机且平均分为两组(每组n = 87),分别每日两次饮用含LcS的发酵乳(益生菌)(3×10CFU/80mL/瓶)或不含LcS的牛奶(安慰剂),持续12周,并进行4周的随访。基线数据包括社会人口学特征、与黄曲霉毒素污染相关的知识、态度和行为、饮食摄入、体重及身体活动状况。每2周和4周分别采集尿液和空腹血样用于AFM和AFB-赖氨酸加合物分析。
益生菌组和安慰剂组分别有85名(n = 85)和82名(n = 82)受试者完成了干预。在调整协变量后,干预后观察到益生菌组有显著效果,与安慰剂组相比,尿AFM浓度降低了23%(B = -0.26;Exp(B)=0.77;P = 0.04)。在整个研究过程中,益生菌组的血清AFB-赖氨酸加合物浓度一直较低。两种黄曲霉毒素生物标志物在不同种族间存在显著差异(AFM:P = 0.001;AFB:P = 0.01)。黄曲霉毒素知识较少的受试者的AFB-赖氨酸浓度(平均秩次 = 95.99)显著高于知识较多的受试者(平均秩次 = 73.57)(P = 0.04)。谷物摄入量增加时尿AFM浓度升高(ρ = )。
种族、知识水平和饮食摄入会影响黄曲霉毒素暴露。食用LcS对降低黄曲霉毒素暴露的益处值得进一步关注。
本试验已在国家医学研究注册库(NMRR-)和美国国立医学图书馆临床试验数据库(NCT03882294)注册。